We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$141M
AUM Growth
-$8.84M
Cap. Flow
-$2.61M
Cap. Flow %
-1.86%
Top 10 Hldgs %
38.31%
Holding
78
New
15
Increased
12
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.25M
2
RYN icon
Rayonier
RYN
+$2.86M
3
CVX icon
Chevron
CVX
+$200K
4
AGN.PRA
Allergan plc
AGN.PRA
+$200K
5
MRK icon
Merck
MRK
+$189K

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$2.68M
2
SHPG
Shire pic
SHPG
+$2.67M
3
MDT icon
Medtronic
MDT
+$2.38M
4
BP icon
BP
BP
+$593K
5
BMO icon
Bank of Montreal
BMO
+$367K

Sector Composition

Rank Sector Weight
1 Financials 20.28%
2 Technology 17.51%
3 Healthcare 16.65%
4 Industrials 10.72%
5 Communication Services 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVN icon
76
Devon Energy
DVN
$51.9B
– –
-60,837
Closed -$2.68M
SHPG
77
DELISTED
Shire pic
SHPG
– –
-13,755
Closed -$2.67M
1 2 3
4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2016 Portfolio in Review

As of Q4 2016, Lipe & Dalton held 78 positions worth $141M, down 5.9% from $149M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2016 filing shows 15 new, 12 increased, 33 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 59,449 shares worth $3.47M. The largest sale was Devon Energy, an estimated $2.68M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Lipe & Dalton's largest Q4 2016 buy was Bristol-Myers Squibb: 59,449 shares worth $3.47M.
  • Lipe & Dalton added most to Allergan plc in Q4 2016, an estimated $200K increase.
  • Lipe & Dalton's biggest Q4 2016 reduction was Medtronic, cutting an estimated $2.38M.
  • Lipe & Dalton fully exited Devon Energy in Q4 2016, selling an estimated $2.68M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $141M portfolio in Q4 2016.
  • Lipe & Dalton opened 15 new positions and closed 3 in Q4 2016.
  • Lipe & Dalton's portfolio value fell 5.9% quarter-over-quarter to $141M.

Based on Lipe & Dalton's 13F filing for Q4 2016, filed 10 Feb 2017.